{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:23:51Z","timestamp":1772713431776,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U24 DA057650"],"award-info":[{"award-number":["U24 DA057650"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01 DA048172"],"award-info":[{"award-number":["K01 DA048172"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA055758"],"award-info":[{"award-number":["K01DA055758"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.josat.2025.209814","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:06:47Z","timestamp":1761008807000},"page":"209814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Developing and validating measures of take-home methadone with administrative data"],"prefix":"10.1016","volume":"180","author":[{"given":"Shashi N.","family":"Kapadia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Karan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Promi","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noa","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209814_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108552","article-title":"Changes in methadone take-home dosing before and after COVID-19","volume":"133","author":"Amram","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.josat.2025.209814_bb0010","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/add.70008","article-title":"State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onset","volume":"120","author":"B\u00f3rquez","year":"2025","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209814_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108449","article-title":"Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19","volume":"131","author":"Brothers","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.josat.2025.209814_bb0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MLR.0000000000001838","article-title":"Measurement approaches to estimating methadone continuity in opioid use disorder care","volume":"61","author":"Busch","year":"2023","journal-title":"Medical Care"},{"key":"10.1016\/j.josat.2025.209814_bb0025","author":"Centers for Medicare & Medicaid Services"},{"key":"10.1016\/j.josat.2025.209814_bb0030","unstructured":"Centers for Medicare & Medicaid Services. (n.d.). Transformed Medicaid Statistical Information System (T-MSIS) Analytic Files (TAF). Retrieved February 14, 2025, from https:\/\/www.medicaid.gov\/medicaid\/data-systems\/macbis\/medicaid-chip-research-files\/transformed-medicaid-statistical-information-system-t-msis-analytic-files-taf\/index.html."},{"issue":"8","key":"10.1016\/j.josat.2025.209814_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.31620","article-title":"Racial and ethnic disparities in take-home methadone use for medicare beneficiaries with opioid use disorder","volume":"7","author":"Choi","year":"2024","journal-title":"JAMA Network Open"},{"issue":"5","key":"10.1016\/j.josat.2025.209814_bb0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/014572179101700506","article-title":"Content, construct, and criterion-related validity","volume":"17","author":"Deane","year":"1991","journal-title":"The Diabetes Educator"},{"key":"10.1016\/j.josat.2025.209814_bb0045","unstructured":"Ene, M., Leighton, E. A., Blue, G. L., & Bell, B. A. (n.d.). Muletilevel Models for Categorical Data Using SAS\u00ae PROC GLIMMIX: The Basics. Retrieved January 6, 2025, from https:\/\/support.sas.com\/resources\/papers\/proceedings15\/3430-2015.pdf."},{"key":"10.1016\/j.josat.2025.209814_bb0050","author":"Federal Register"},{"key":"10.1016\/j.josat.2025.209814_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108276","article-title":"Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19","volume":"123","author":"Figgatt","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209814_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108801","article-title":"Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis","volume":"141","author":"Hoffman","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209814_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108288","article-title":"Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study","volume":"124","author":"Hunter","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209814_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108219","article-title":"Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19","volume":"122","author":"Joseph","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.josat.2025.209814_bb0075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/ADM.0000000000000981","article-title":"Shifting medication treatment practices in the COVID-19 pandemic: A statewide survey of Pennsylvania opioid treatment programs","volume":"16","author":"Krawczyk","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2025.209814_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109100","article-title":"Treatment provider perceptions of take-home methadone regulation before and during COVID-19","volume":"228","author":"Madden","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2025.209814_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019","volume":"5","author":"Mauro","year":"2022","journal-title":"JAMA Network Open"},{"issue":"S2","key":"10.1016\/j.josat.2025.209814_bb0090","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.2105\/AJPH.2021.306665","article-title":"The methadone manifesto: treatment experiences and policy recommendations from methadone patient activists","volume":"112","author":"Simon","year":"2022","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2025.209814_bb0095","series-title":"Opioid Treatment Program (OTP) Guidance","author":"Substance Abuse and Mental Health Services Administration","year":"2020"},{"issue":"1","key":"10.1016\/j.josat.2025.209814_bb0100","first-page":"1143","article-title":"\u201cThe idea is to help people achieve greater success and liberty\u201d: A qualitative study of expanded methadone take-home access in opioid use disorder treatment","volume":"43","author":"Suen","year":"2022","journal-title":"Substance Abuse\u00a0: Official Publication of the Association for Medical Education and Research in Substance Abuse"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T21:54:44Z","timestamp":1764712484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925001936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":20,"alternative-id":["S2949875925001936"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209814","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing and validating measures of take-home methadone with administrative data","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209814","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209814"}}